SCHEMBL30831046

SCHEMBL30831046

COC(=O)c1ccc([C@H]2C[C@@H](NC(=O)OC(C)(C)C)CN(C)C2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4D Q6B0I6 2/20 0.45
▸ TSHR P16473 2/20 0.42
▸ HSD17B10 Q99714 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ CASP1 P29466 1/20 0.42
▸ CASP7 P55210 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ BTK Q06187 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ F2R P25116 2/20 0.41
▸ KDM1A O60341 2/20 0.40
▸ MAOB P27338 1/20 0.40
▸ CYP2C9 P11712 1/20 0.39
▸ HSD11B1 P28845 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ GRIN2B Q13224 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31091756 1.00 KDM4D (0.45) KDM4DTSHRHSD17B10KDM4EALDH1A1
SCHEMBL31091687 0.86 KMT2A (0.42) GAABTKKMT2AL3MBTL1F2R
SCHEMBL17916741 0.86 KDM1A (0.54) BTKKMT2AL3MBTL1KDM1AMAOB
SCHEMBL21232571 0.83 KMT2A (0.49) KDM4DTSHRHSD17B10KDM4EALDH1A1
SCHEMBL21221554 0.83 KDM1A (0.48) KDM4DTSHRHSD17B10KDM4EALDH1A1
SCHEMBL21232465 0.83 KDM1A (0.48) KDM4DTSHRHSD17B10KDM4EALDH1A1
SCHEMBL21232441 0.83 KMT2A (0.49) KDM4DTSHRHSD17B10KDM4EALDH1A1
SCHEMBL21232595 0.81 BTK (0.52) KDM4DTSHRHSD17B10KDM4EALDH1A1
SCHEMBL22382254 0.81 BTK (0.52) KDM4DTSHRHSD17B10KDM4EALDH1A1
SCHEMBL21221573 0.81 BTK (0.52) KDM4DTSHRHSD17B10KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4581025-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS Auron Therapeutics, Inc. (US) 2025-07-09 — — EP disclosed
WO-2024220843-A1 TECHNOLOGIES TARGETING CELL STATES AURON THERAPEUTICS, INC. (US) 2024-10-24 — — WO disclosed
WO-2024050078-A1 PYRIDAZINON DERIVATIVES AS KAT2 DEGRADERS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS AURON THERAPEUTICS, INC. (US) 2024-03-07 — — WO disclosed
Send feedback